Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: A possible in Vitro model for postexposure prophylaxis of sexual HIV transmission

AIDS Research and Human Retroviruses

Volumn 18, Issue 15, 2002, Pages 1091-1102

  Van Herrewege, Yven ^a   Penne, Lieve ^a   Vereecken, Chris ^a   Fransen, Katrien ^a   Van der Groen, Guido ^a   Kestens, Luc ^a   Balzarini, Jan ^b   Vanham, Guido ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ADEFOVIR; AUTOANTIGEN; CD4 ANTIGEN; EFAVIRENZ; INTERLEUKIN 2; LAMIVUDINE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; PHYTOHEMAGGLUTININ; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ANIMAL CELL; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE MODEL; DRUG EFFECT; DRUG POTENCY; DRUG SENSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; MIXED LEUKOCYTE CULTURE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SEXUAL TRANSMISSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOPREVENTION; COCULTURE TECHNIQUES; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; LANGERHANS CELLS; LYMPHOCYTE ACTIVATION; MODELS, BIOLOGICAL; MONOCYTES; REVERSE TRANSCRIPTASE INHIBITORS; VIRUS REPLICATION;

EID: 0036402243     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202320567833     Document Type: Article

References (50)

1. Katz MH and Gerberding JL: The care of persons with recent sexual exposure to HIV. Ann Intern Med 1998;128:306-312.
2. Bamberger JD, Waldo CR, Gerberding JL, and Katz MH: Postexposure prophylaxis for human immunodeficiency virus (HIV) infection following sexual assault. Am J Med 1999;106:323-326.
3. Kahn JO and Walker BD: Acute human immunodeficiency virus type 1 infection. N Engl J Med 1998;339:33-39.
4. De-Clercq E: Reverse transcriptase inhibitors as anti-HIV drugs. In: Antivirals against AIDS. (Unger RE, Kreuter J, and Rübsamen-Waigmann H, eds.). Marcel Dekker, New York, 2000, pp. 108-150.
5. Simpson BJ, Shapiro ED, and Andiman WA: Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:145-152.
6. Mofenson LM and Fowler MG: Interruption of materno-fetal transmission. AIDS 1999;13 (Suppl A):S205-S214
7. Guay LA, Musoke P, Fleming T, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
8. Cardo DM, Culver DH, Ciesielski CA, et al.: A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997;337:1485-1490.
9. Tsai CC, Follis KE, Sabo A, et al.: Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science 1995;270:1197-1199.
10. Tsai CC, Emau P, Follis KE, et al.: Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl)adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol 1998;72:4265-4273.
11. Mori K, Yasutomi Y, Sawada S, et al.: Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection. J Virol 2000;74:5747-5753.
12. Otten RA, Smith DK, Adams DR, et al.: Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000;74:9771-9775.
13. Milman G and Sharma O: Mechanisms of HIV/SIV mucosal transmission. AIDS Res Hum Retroviruses 1994;10:1305-1312.
14. Spira AI, Marx PA, Patterson BK, et al.: Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996;183:215-225.
15. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-296.
16. Zoeteweij JP and Blauvelt A: HIV-dendritic cell interactions promote efficient viral infection of T cells. J Biomed Sci 1998;5:253-259.
17. Masurier C, Salomon B, Guettari N, et al.: Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice. J Virol 1998;72:7822-7829.
18. Schuitemaker H: Macrophage-tropic HIV-1 variants: Initiators of infection and AIDS pathogenesis? J Leukoc Biol 1994;56:218-224.
19. Rodrigo AG: Dynamics of syncytium-inducing and non-syncytium-inducing type 1 human immunodeficiency viruses during primary infection. AIDS Res Hum Retroviruses 1997;13:1447-1451.
20. Sallusto F and Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994;179:1109-1118.
21. Romani N, Gruner S, Brang D, et al.: Proliferating dendritic cell progenitors in human blood. J Exp Med 1994;180:83-93.
22. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N, and Hermine O: Transforming growth factor β1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 1998;187:961-966.
23. Vanham G, van Tendeloo, V, Willems B, et al.: The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells. J Med Virol 2000;60:300-312.
24. Vanham G, Penne L, Allemeersch H, et al.: Modeling HIV transfer between dendritic cells and T cells: Importance of HIV phenotype, dendritic cell-T cell contact and T-cell activation. AIDS 2000;14:2299-2311.
25. Reed LJ and Muench H: A simple method of estimating fifty percent endpoints. Am J Hyg 1938;27:493-497.
26. Peden KWC, Martin MA, Karn J: Virological and molecular genetic techniques for studies of established HIV isolates. In: A Practical Approach to HIV Virology and Immunology. Karn J, ed. Oxford University Press, New York, 1995, pp. 21-45.
27. Beirnaert E, Willems B, Peeters M, et al.: Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J Virol Methods 1998;73:65-70.
28. Balzarini J, De Clercq E, Carbonez A, Burt V, and Kleim JP: Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors. AIDS Res Hum Retroviruses 2000;16:517-528.
29. Christopherson C, Kidane Y, Conway B, Krowka J, Sheppard H, and Kwok S: PCR-based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells. J Clin Microbiol 2000;38:630-634.
30. Reece JC, Handley AJ, Anstee EJ, Morrison WA, Crowe SM, and Cameron PU: HIV-1 selection by epidermal dendritic cells during transmission across human skin. J Exp Med 1998;187:1623-1631.
31. Vanham G, Davis D, Willems B, et al.: Dendritic cells, exposed to primary, mixed phenotype HIV-1 isolates preferentially, but not exclusively, replicate CCR5-using clones. AIDS 2000;14:1874-1876.
32. Geijtenbeek TB, Kwon DS, Torensma R, et al.: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100:587-597.
33. Geijtenbeek TB, Torensma R, van Vliet SJ, et al.: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000;100:575-585.
34. Langhoff E, Terwilliger EF, Bos HJ, et al.: Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures. Proc Natl Acad Sci USA 1991;88:7998-8002.
35. Cameron PU, Lowe MG, Crowe SM, et al.: Susceptibility of dendritic cells to HIV-1 infection in vitro. J Leukoc Biol 1994;56:257-265.
36. Ayehunie S, Groves RW, Bruzzese AM, Ruprecht RM, Kupper TS, and Langhoff E: Acutely infected Langerhans cells are more efficient than T cells in disseminating HIV type 1 to activated T cells following a short cell-cell contact. AIDS Res Hum Retroviruses 1995;11:877-884.
37. Zaitseva M, Blauvelt A, Lee S, et al.: Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: Implications for HIV primary infection. Nat Med 1997;3:1369-1375.
38. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, and Shattock RJ: Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000;74:5577-5586.
39. + dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection. AIDS 2002;16:683-692.
40. Peter K and Gambertoglio JG: Intracellular phosphorylation of zidovudine (ZDV) and other nucleoside reverse transcriptase inhibitors (RTI) used for human immunodeficiency virus (HIV) infection. Pharm Res 1998;15:819-825.
41. Gao WY, Shirasaka T, Johns DG, Broder S, and Mitsuya H: Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest 1993;91:2326-2333.
42. Balzarini J, Perno CF, Schols D, and De-Clercq E: Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes. Biochem Biophys Res Commun 1991;178:329-335
43. Perno CF, Yarchoan R, Balzarini J, et al.: Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocyte/macrophages. Antiviral Res 1992;17:289-304.
44. Aquaro S, Perno CF, Balestra E, et al.: Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes. J Leukoc Biol 1997;62:138-143.
45. + T cells. J Immunol 1995;155:4111-4117.
46. Balzarini J, Van Herrewege Y, Vanham G: Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and langerhans cells. AIDS (in press).
47. Carr A and Cooper DA: HIV protease inhibitors. AIDS 1996;10 (Suppl A):S151-S157.
48. Hazuda DJ, Felock P, Witmer M, et al.: Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 2000;287:646-650.
49. Kilby JM, Hopkins S, Venetta TM, et al.: Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 1998;4:1302-1307.
50. Root MJ, Kay MS, and Kim PS: Protein design of an HIV-1 entry inhibitor. Science 2001;291:884-888.